Status:
RECRUITING
E²-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Conditions:
Cancer
Eligibility:
All Genders
12+ years
Brief Summary
The primary objective is the collection of real-world data of cancer patients treated with radiotherapy, to support radiotherapy research and to provide evidence of the role of radiation oncology in a...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Pathologically confirmed cancer.
- Written informed consent for E²-RADIatE according to applicable legal and ethical requirements
- Planned use of radiotherapy
- Eligibility of the patient confirmed for at least one cohort confirmed
- Patients of 12 years and older
Exclusion
Key Trial Info
Start Date :
June 24 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT03818503
Start Date
June 24 2019
End Date
April 30 2026
Last Update
March 21 2025
Active Locations (77)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Graz - Radio-oncology
Graz, Austria, AT 8036
2
Ordensklinikum Linz-Barmherzige Schwestern
Linz, Austria, AT 4010
3
Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH unikliniken
Vienna, Austria, AT 1090
4
Onze Lieve Vrouw Ziekenhuis
Aalst, Belgium, 9300